-
-
-
-
-
-
-
FDA approves Moderna's updated 2026-2027 COVID-19 vaccines
-
-
-
-
-
-
-
Moderna stock pulls back after massive one-day rally: analysts weigh in
-
-
-
-
-
-
-
Moderna short sellers face $4.8 billion loss amid record stock jump
-
-
-
-
-
-
-
Trump Administration Weighs Order On Autism And Vaccines - Bloomberg
-
-
-
-
-
-
-
U.S. biopharma earnings: Eli Lilly (LLY), Pfizer (PFE) take the stage
-
-
-
-
-
-
-
Moderna (MRNA) call put ratio 3.5 calls to 1 put with a focus on July 72 and 77 calls as share price down 9.5%
-
-
-
-
-
-
-
From Vaccines to Therapeutics; How Biotech Is Addressing the Ebola Outbreak
-
458,235 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

